2Anonymous.Adjusted-dose warfarin versus low-intensity,tixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: srtoke prevention in atrial fibrillation,Ⅲ randomized clinical trial. Lancet,1996,384:633
3Toschi V,Gallo R,Lettino M,et al Tissues factor modulates the thrombogenicity of human atherosclerotlc plaques.Circulation,1997,95(3):594
4Ruddock V,Meade TW. Factor Ⅶ activity and ischaemic heart disease:fatal and non-fatal events.QJM,1994,87(7):403
5Holm J,Hillarp A, Erhardt L,et al.Changes in levels of factor Ⅶ and protein S after acute myocardial infarction: effects of low-dose warfarin. Thromb Res,1999,96(3):205
6Anand SS. The organization to Assess Strategies for lschemic Syndromes(OASIS),Pilot Study:evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation.Am J Cardial,1999,84(5A):13M
7Al-Khadra AS, Salem DN, Rand WM, et al , Warfarin anticoagulation and survival: a cohort analysis from the studies of left ventricular dysfunction. J Am Coll Cardiol,1998,31(4):749
5Braunwald E,Antman EM,Beasley JW,et al.ACC/AHA guide line update for the management of patients with unstable angina and non-STsegment myocardial infarction:a report of the american college of cardiology/merican heart association ask force on practic guidelines(committee on the management of patients with unstable angina)[J]J Am CollCardio,2002,37(7):1366-1374.
6Latour-Pérez J,Navarro-Ruiz A,Ridao-López M,et al.Using clopidogrel in non-ST-segment elevation acute coronary syndrome patients:a cost-utility analysis in Spain[J].Value Health,2004,7(1):52.
7Motsko SP,Russmann S,Ming EE,et al.Effectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events-a cohort study in 395 039 patients from clinical practice[J].Pharmacoepidemiol Drug Saf,2009,18(12):1214.
